» Articles » PMID: 20231911

Interaction Trees with Censored Survival Data

Overview
Journal Int J Biostat
Specialty Public Health
Date 2010 Mar 17
PMID 20231911
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

We propose an interaction tree (IT) procedure to optimize the subgroup analysis in comparative studies that involve censored survival times. The proposed method recursively partitions the data into two subsets that show the greatest interaction with the treatment, which results in a number of objectively defined subgroups: in some of them the treatment effect is prominent while in others the treatment may have a negligible or even negative effect. The resultant tree structure can be used to explore the overall interaction between treatment and other covariates and help identify and describe possible target populations on which an experimental treatment demonstrates desired efficacy. We follow the standard CART (Breiman, et al., 1984) methodology to develop the interaction tree structure. Variable importance information is extracted via random forests of interaction trees. Both simulated experiments and an analysis of the primary billiary cirrhosis (PBC) data are provided for evaluation and illustration of the proposed procedure.

Citing Articles

Bayesian Nonparametric Model for Heterogeneous Treatment Effects With Zero-Inflated Data.

Kim C, Li Y, Xu T, Liao Z Stat Med. 2024; 43(30):5968-5982.

PMID: 39608809 PMC: 11834965. DOI: 10.1002/sim.10266.


Tree-based subgroup discovery using electronic health record data: heterogeneity of treatment effects for DTG-containing therapies.

Yang J, Mwangi A, Kantor R, Dahabreh I, Nyambura M, DeLong A Biostatistics. 2023; 25(2):323-335.

PMID: 37475638 PMC: 11017113. DOI: 10.1093/biostatistics/kxad014.


Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review.

Al-Tashi Q, Saad M, Muneer A, Qureshi R, Mirjalili S, Sheshadri A Int J Mol Sci. 2023; 24(9).

PMID: 37175487 PMC: 10178491. DOI: 10.3390/ijms24097781.


Using machine learning to advance disparities research: Subgroup analyses of access to opioid treatment.

Kong Y, Zhou J, Zheng Z, Amaro H, Guerrero E Health Serv Res. 2021; 57(2):411-421.

PMID: 34657287 PMC: 8928038. DOI: 10.1111/1475-6773.13896.


An Application of the Patient Rule-Induction Method to Detect Clinically Meaningful Subgroups from Failed Phase III Clinical Trials.

Dyson G Int J Clin Biostat Biom. 2021; 7(1).

PMID: 34632463 PMC: 8496893. DOI: 10.23937/2469-5831/1510038.


References
1.
Song Y, Chi G . A method for testing a prespecified subgroup in clinical trials. Stat Med. 2007; 26(19):3535-49. DOI: 10.1002/sim.2825. View

2.
Sleight P . Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!. Curr Control Trials Cardiovasc Med. 2001; 1(1):25-27. PMC: 59592. DOI: 10.1186/cvm-1-1-025. View

3.
Su X, Fan J . Multivariate survival trees: a maximum likelihood approach based on frailty models. Biometrics. 2004; 60(1):93-9. DOI: 10.1111/j.0006-341X.2004.00139.x. View

4.
Keles S, Segal M . Residual-based tree-structured survival analysis. Stat Med. 2002; 21(2):313-26. DOI: 10.1002/sim.981. View

5.
Cook D, Gebski V, Keech A . Subgroup analysis in clinical trials. Med J Aust. 2004; 180(6):289-91. DOI: 10.5694/j.1326-5377.2004.tb05928.x. View